Aclaris Therapeutics, Inc.

and Exhibit 99.1 hereto shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “ Exchange Act ”), or oth

Financial Statements and Exhibits. ​ (d) Exhibits ​ ​ ​ Exhibit ​ Number ​ Exhibit Description 99.1 ​ Press Release, dated February 26, 2026. 104 ​ The cover pa